INSR and cancer: For the PPTP/C models, higher INSR expression was associated with reduced activity of cixutumumab, consistent with results for adult cancer models showing that signaling through both IR-A and IR-B can mediate resistance to antibodies blocking IGF1R signaling (Forest et al., 2015).